US Supreme Court hears Microsoft case on patents

Canadian technology company claims some versions of Word violated its patent.

AFP | April 19, 2011



The US Supreme Court immersed itself in patent rules in a case pitting Microsoft against a Canadian technology company that claims some versions of Word violated its patent.

Eight of the nine judges -- the chief justice recused himself -- questioned the companies' lawyers yesterday at length on whether rules for challenging the validity of patents should be changed.

Beyond the battle between the US software giant and Toronto-based i4i, at stake is the future of distribution of patents in the United States.

A Microsoft victory would make it harder for patent holders to prove infringements. But if the court sides with i4i, some say it would stifle innovation.

"It's a bad thing not to give protection to an invention that deserves it; and it is just as bad a thing to give protection to an invention that doesn't deserve it," justice Stephen Breyer said. "Both can seriously harm the economy."

Microsoft wants those accused in infringement cases to be able to prove a patent invalid by showing a "preponderance of evidence," rather than the tougher standard of "clear and convincing evidence" that it was held to in this case.

In 2007, a lower court ordered Microsoft to pay USD 290 million to i4i for patent infringement related to the Canadian company's rights to XML technology.

A decision is expected by the end of June.
 

Comments

 

Other News

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Who checks the books?

I read about the news about the Coimbatore library over coffee this morning. On the face of it, the headline was about a political ‘war’ between the DMK and TVK. But what stayed with me was something much more important than the blame game behind what had transpired. A writer walking through

Development paradox: Falling poverty miracle and an inequality problem

India’s reduction in poverty over the past decade is a development achievement of considerable significance. The World Bank’s April 2026 ‘India Development Update’ estimates that the share of Indians living below the international extreme-poverty line of $3.00 per person per day i

In Arunachal, a river we call mother

In Arunachal Pradesh, the Siang is not just a river. For many of us, especially the Adi people, it is part of our family. Our grandparents fished in it. Children learned to swim in it. Our farms drink from it. When someone says a huge dam will be built on it, we do not hear the word "project".

A new retelling of the Mahabharata delves into key moments

In a time when every decision carries consequences and questions of ambition, power, loyalty, identity and moral choice continue to shape our lives, Dr. Arun Krishnan’s new book, ‘Mahakshana’ (Penguin India) offers a strikingly relevant retelling of the Mahabharata.  

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter